Page 2 - Corporate Clinics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Joint (NASDAQ:JYNT) Given Buy Rating at Roth Mkm

Joint (NASDAQ:JYNT) Given Buy Rating at Roth Mkm
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRoth mkmFirst foundation advisorsSkylands capitalCompany profileFree reportStock downGet free reportBay capital managementFoundation advisorsCorporate clinicsJoint daily

B Riley Increases Joint (NASDAQ:JYNT) Price Target to $20 00

B Riley Increases Joint (NASDAQ:JYNT) Price Target to $20 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesRoth mkmBridge city capitalBard associates incSierra summit advisorsGet free reportCity capitalWealth managementSummit advisorsBard associatesCorporate clinicsJoint daily

Joint s (JYNT) Buy Rating Reiterated at Roth Mkm

Joint s (JYNT) Buy Rating Reiterated at Roth Mkm
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesRoth mkmBrien greene coVerus capital partnersFirst foundation advisorsSkylands capitalFree reportStock downGet free reportFoundation advisorsCapital partnersBrien greeneHudson bay capital managementCorporate clinicsJoint daily

The Joint Corp (NASDAQ:JYNT) Receives Consensus Rating of Moderate Buy from Brokerages

The Joint Corp (NASDAQ:JYNT) Receives Consensus Rating of Moderate Buy from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesRoth mkmConnor clark lunn investment management ltdBarclays plcGet free reportStock downLunn investment managementStrs ohioGet freeCorporate clinicsJoint daily

Joint (NASDAQ:JYNT) Receives Buy Rating from Roth Mkm

Joint (NASDAQ:JYNT – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Roth Mkm in a report released on Friday, Benzinga reports. They currently have a $16.00 price target on the stock, up from their prior price target of $13.00. Roth Mkm’s price target suggests a potential upside of 4.10% from […]

United statesRoth mkmSkylands capitalFirst foundation advisorsGet free reportBay capital managementFoundation advisorsCorporate clinicsJoint dailyNasdaq jyntReiterated rating